Athira Pharma, Inc. (ATHA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 32.37M |
| Enterprise Value | -36.11M |
| P/E Ratio | -0.27 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.72 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.81 |
| Return On Equity | -3.81 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -68.09M |
| EBITDA | 643,000 |
| Net Income | -105.61M |
| Diluted EPS | -24.7 |
| Total Cash | 67.68M |
| Total Cash/Share | 15.83 |
| Total Debt | 691,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 10.38 |
| Book Value Per Share | 11.53 |
| 52-Week Change | 53.06 |
| 52-Week High | 8.36 |
| 52-Week Low | 2.2 |
| Moving Average 50 Days | 5.48 |
| Moving Average 200 Days | 4.03 |
| Average Volume | 1.06M |
| Shares Outstanding | 3.94M |
| % Held by Institutions | 157.34 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | September 18, 2025 |